214 related articles for article (PubMed ID: 17548501)
1. Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics.
Korycka-Machala M; Rychta E; Brzostek A; Sayer HR; Rumijowska-Galewicz A; Bowater RP; Dziadek J
Antimicrob Agents Chemother; 2007 Aug; 51(8):2888-97. PubMed ID: 17548501
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and genetic analysis of the four DNA ligases of mycobacteria.
Gong C; Martins A; Bongiorno P; Glickman M; Shuman S
J Biol Chem; 2004 May; 279(20):20594-606. PubMed ID: 14985346
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
[TBL] [Abstract][Full Text] [Related]
4. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DNA primase DnaG as a potential target for antibiotics.
Kuron A; Korycka-Machala M; Brzostek A; Nowosielski M; Doherty A; Dziadek B; Dziadek J
Antimicrob Agents Chemother; 2014; 58(3):1699-706. PubMed ID: 24379196
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
[TBL] [Abstract][Full Text] [Related]
7. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.
Kaczmarek FS; Zaniewski RP; Gootz TD; Danley DE; Mansour MN; Griffor M; Kamath AV; Cronan M; Mueller J; Sun D; Martin PK; Benton B; McDowell L; Biek D; Schmid MB
J Bacteriol; 2001 May; 183(10):3016-24. PubMed ID: 11325928
[TBL] [Abstract][Full Text] [Related]
9. Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD
Shukla A; Afsar M; Kumar N; Kumar S; Ramachandran R
J Struct Biol; 2021 Mar; 213(1):107655. PubMed ID: 33197566
[TBL] [Abstract][Full Text] [Related]
10. Stable, temperature-sensitive recombinant strain of Mycobacterium smegmatis generated through the substitution of a psychrophilic ligA gene.
Pinto CT; Nano FE
FEMS Microbiol Lett; 2015 Sep; 362(18):fnv152. PubMed ID: 26337150
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ligation and DNA binding by Escherichia coli DNA ligase (LigA).
Wilkinson A; Smith A; Bullard D; Lavesa-Curto M; Sayer H; Bonner A; Hemmings A; Bowater R
Biochim Biophys Acta; 2005 May; 1749(1):113-22. PubMed ID: 15848142
[TBL] [Abstract][Full Text] [Related]
12. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
Singh V; Somvanshi P
Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
[TBL] [Abstract][Full Text] [Related]
14. NAD+-dependent DNA ligases of Mycobacterium tuberculosis and Streptomyces coelicolor.
Wilkinson A; Sayer H; Bullard D; Smith A; Day J; Kieser T; Bowater R
Proteins; 2003 May; 51(3):321-6. PubMed ID: 12696044
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting NAD+-dependent DNA ligase activity with 2-(cyclopentyloxy)-5'-deoxyadenosine (CPOdA) offers a new tool for DNA replication and repair studies in the model archaeon Haloferax volcanii.
Giroux X; MacNeill SA
FEMS Microbiol Lett; 2015 Nov; 362(21):. PubMed ID: 26420852
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
Bi F; Ma R; Ma S
Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic assessment of DNA ligase as an antibacterial target in Staphylococcus aureus.
Podos SD; Thanassi JA; Pucci MJ
Antimicrob Agents Chemother; 2012 Aug; 56(8):4095-102. PubMed ID: 22585221
[TBL] [Abstract][Full Text] [Related]
18. Homology modeling of NAD+-dependent DNA ligase of the Wolbachia endosymbiont of Brugia malayi and its drug target potential using dispiro-cycloalkanones.
Shrivastava N; Nag JK; Pandey J; Tripathi RP; Shah P; Siddiqi MI; Misra-Bhattacharya S
Antimicrob Agents Chemother; 2015 Jul; 59(7):3736-47. PubMed ID: 25845868
[TBL] [Abstract][Full Text] [Related]
19. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
[TBL] [Abstract][Full Text] [Related]
20. Two-metal versus one-metal mechanisms of lysine adenylylation by ATP-dependent and NAD
Unciuleac MC; Goldgur Y; Shuman S
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2592-2597. PubMed ID: 28223499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
